HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pentostatin plus cyclophosphamide and bexarotene is an effective and safe combination in patients with mycosis fungoides/Sezary syndrome.

AuthorsCristina Calderon Cabrera, Fatima de la Cruz Vicente, Ana Marín-Niebla, Estrella Carrillo Cruz, Eduardo Rios Herranz, Ildefonso Espigado Tocino, Concepción Prats Martín, Jose F Falantes, María L Martino Galiana, Jose A Perez-Simón
JournalBritish journal of haematology (Br J Haematol) Vol. 162 Issue 1 Pg. 130-2 (Jul 2013) ISSN: 1365-2141 [Electronic] England
PMID23581433 (Publication Type: Letter)
Chemical References
  • Tetrahydronaphthalenes
  • Pentostatin
  • Cyclophosphamide
  • Bexarotene
Topics
  • Antineoplastic Combined Chemotherapy Protocols (adverse effects, therapeutic use)
  • Bexarotene
  • Cyclophosphamide (administration & dosage)
  • Humans
  • Mycosis Fungoides (drug therapy)
  • Pentostatin (administration & dosage)
  • Sezary Syndrome (drug therapy)
  • Skin Neoplasms (drug therapy)
  • Tetrahydronaphthalenes (administration & dosage)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: